常规软骨肉瘤中胸部与骨骼分期检查的价值
回顾性分析2007年1月至2019年12月诊断的420例常规软骨肉瘤患者,比较不同组织学分级(低级别、高级别、去分化)中胸部CT和全身骨扫描的转移检出率。去分化软骨肉瘤胸部CT转移检出率为30%、骨扫描为21%,而低级别和高级别者转移检出率均很低,提示分期检查除去分化软骨肉瘤外价值有限。
要点
- 去分化软骨肉瘤患者胸部CT转移检出率30%、全身骨扫描21%,分期检查价值主要见于该组。
- 低级别软骨肉瘤胸部CT转移检出率3.3%、骨扫描0%,高级别分别为4.3%和0%。
- 常规软骨肉瘤分期胸部CT和全身骨扫描除去分化型外价值很小或无价值。
核心结论
- 胸部CT和全身骨扫描分期检查除去分化软骨肉瘤外价值很小或无价值。
研究设计与样本
- 回顾性分析2007年1月至2019年12月诊断的420例常规软骨肉瘤患者(234例男性,186例女性,平均年龄54.5岁,范围9-91岁)。
- 收集初诊时胸部CT和全身骨扫描结果,并与手术切除或穿刺活检的组织学分级(低级别、高级别、去分化)进行相关性分析。
诊断标准与关键数值
- 低级别软骨肉瘤:胸部CT转移检出率3.3%(2例),全身骨扫描0例。
- 高级别软骨肉瘤:胸部CT转移检出率4.3%(8例),全身骨扫描0例。
- 去分化软骨肉瘤:胸部CT转移检出率30%(21例),全身骨扫描21%(6例)。
临床应用与阅片要点
- 常规软骨肉瘤初诊分期时,低级别和高级别患者胸部CT及全身骨扫描转移检出率低,去分化软骨肉瘤患者转移检出率较高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the value of chest and skeletal staging in patients presenting with conventional chondrosarcoma (CS).
MATERIALS AND METHODS: Retrospective review of patients with CS diagnosed between January 2007 and December 2019. Data collected included age, sex, skeletal location and results of chest CT and whole-body bone scintigraphy (WB-BSc) obtained at initial diagnosis. The histological tumour grade based on surgical resection or needle biopsy was classified as low-grade (LGCT), high-grade (HGCT) and dedifferentiated (DD-CS). Findings of chest CT and WB-BSc were correlated with tumour grade.
RESULTS: Four hundred twenty patients were included (234 males and 186 females with mean age 54.5 years, range 9-91 years). The major long bones were involved in 205 cases, the flat bones in 166 cases, the mobile spine in 14 cases and the small bones of the hands and feet in 35 cases. Three hundred fifty tumours were central in location, 39 peripheral and 31 on the surface of the bone. There were 151 LGCTs, 196 HGCTs and 73 DD-CSs. Of patients with LGCT, 41.7% underwent chest CT and 25.2% WB-BSc. Of patients with HGCT, 95.4% underwent chest CT and 76.5% WB-BSc. Of patients with DD-CS, 98.6% underwent chest CT and 86.3% WB-BSc. Metastases were diagnosed in 2 (3.3%) chest CT studies and 0 WB-BSc in LGCT, in 8 (4.3%) chest CT studies and 0 WB-BSc in HGCT and in 21 (30%) chest CT studies and 6 (21%) WB-BSc in DD-CS.
DISCUSSION: Staging chest CT and WB-BSc is of little or no value except in DD-CS.
引用
- Oliveira I, Singla N, Chavda A, et al. The value of chest and skeletal staging studies in conventional chondrosarcoma. Skeletal Radiol. 2020. PMID: 32666323. doi:10.1007/s00256-020-03539-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。